Access

Technology Feature

Nature 425, 867 (23 October 2003) | doi:10.1038/425867b

Lighting up the body

The ability to track the molecular action of disease or other biological processes within live subjects is a potentially invaluable tool for studying the broad array of drug targets identified by genomic and proteomic research.Medical imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) can be deployed, but they demand expensive equipment beyond the reach of many labs and provide limited functional information.